Search research articles
Contact Us
Filters
Showing results (221-230 of 343) with videos related to
Page
of 35
Sort By:
JCI Insight
|
December 7, 2023
CRISPR screening identifies BET and mTOR inhibitor synergy in cholangiocarcinoma through serine glycine one carbon
Yan Zhu, Dengyong Zhang, Pooja Shukla, et al.
JAMA Oncology
|
April 19, 2019
Gemcitabine, Cisplatin, and nab-Paclitaxel for the Treatment of Advanced Biliary Tract Cancers: A Phase 2 Clinical Trial
Rachna T Shroff, Milind M Javle, Lianchun Xiao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 29, 2011
Phase II trial of cetuximab, gemcitabine, and oxaliplatin followed by chemoradiation with cetuximab for locally advanced (T4) pancreatic adenocarcinoma: correlation of Smad4(Dpc4) immunostaining with pattern of disease progression
Christopher H Crane, Gauri R Varadhachary, John S Yordy, et al.
JAMA Surgery
|
July 16, 2020
Response and Survival Associated With First-line FOLFIRINOX vs Gemcitabine and nab-Paclitaxel Chemotherapy for Localized Pancreatic Ductal Adenocarcinoma
Giampaolo Perri, Laura Prakash, Wei Qiao, et al.
Annals of Surgery
|
January 3, 2020
Postoperative Chemotherapy Benefits Patients Who Received Preoperative Therapy and Pancreatectomy for Pancreatic Adenocarcinoma
Giampaolo Perri, Laura Prakash, Wei Qiao, et al.
The Oncologist
|
March 26, 2025
A phase I/II trial of avelumab combinations with ivuxolimab, utomilumab, and radiation therapy in patients with advanced gastrointestinal malignancies
Jibran Ahmed, Anne Knisely, Carlos Torrado, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 14, 2025
HER2-Positivity as a Prognostic Biomarker and Therapeutic Target in Advanced Biliary Tract Cancer: A Multi-Institutional Analysis
Sunyoung S Lee, Dong Hyun Seo, Taek Chung, et al.
Molecular Cancer
|
March 27, 2024
RAF inhibitor re-challenge therapy in BRAF-aberrant pan-cancers: the RE-RAFFLE study
Blessie Elizabeth Nelson, Jason Roszik, Jibran Ahmed, et al.
Pancreas
|
March 14, 2014
Should combination chemotherapy serve as the backbone in clinical trials of advanced pancreatic cancer? A pooled analysis of phase II trials of gemcitabine-containing doublets plus bevacizumab
Katherine Van Loon, Anne M Espinoza, David R Fogelman, et al.
Journal of Immunotherapy and Precision Oncology
|
January 16, 2025
Safety and Efficacy of Toripalimab in Patients with Cholangiocarcinoma: An Open-Label, Phase 1 Study
Aung Naing, Amit Mahipal, Milind Javle, et al.
Page
of 35
Search research articles
Search
Showing results (221-230 of 343) with videos related to
Sort By:
Page
of 35
JCI Insight
|
December 7, 2023
CRISPR screening identifies BET and mTOR inhibitor synergy in cholangiocarcinoma through serine glycine one carbon
Yan Zhu, Dengyong Zhang, Pooja Shukla, et al.
JAMA Oncology
|
April 19, 2019
Gemcitabine, Cisplatin, and nab-Paclitaxel for the Treatment of Advanced Biliary Tract Cancers: A Phase 2 Clinical Trial
Rachna T Shroff, Milind M Javle, Lianchun Xiao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 29, 2011
Phase II trial of cetuximab, gemcitabine, and oxaliplatin followed by chemoradiation with cetuximab for locally advanced (T4) pancreatic adenocarcinoma: correlation of Smad4(Dpc4) immunostaining with pattern of disease progression
Christopher H Crane, Gauri R Varadhachary, John S Yordy, et al.
JAMA Surgery
|
July 16, 2020
Response and Survival Associated With First-line FOLFIRINOX vs Gemcitabine and nab-Paclitaxel Chemotherapy for Localized Pancreatic Ductal Adenocarcinoma
Giampaolo Perri, Laura Prakash, Wei Qiao, et al.
Annals of Surgery
|
January 3, 2020
Postoperative Chemotherapy Benefits Patients Who Received Preoperative Therapy and Pancreatectomy for Pancreatic Adenocarcinoma
Giampaolo Perri, Laura Prakash, Wei Qiao, et al.
The Oncologist
|
March 26, 2025
A phase I/II trial of avelumab combinations with ivuxolimab, utomilumab, and radiation therapy in patients with advanced gastrointestinal malignancies
Jibran Ahmed, Anne Knisely, Carlos Torrado, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 14, 2025
HER2-Positivity as a Prognostic Biomarker and Therapeutic Target in Advanced Biliary Tract Cancer: A Multi-Institutional Analysis
Sunyoung S Lee, Dong Hyun Seo, Taek Chung, et al.
Molecular Cancer
|
March 27, 2024
RAF inhibitor re-challenge therapy in BRAF-aberrant pan-cancers: the RE-RAFFLE study
Blessie Elizabeth Nelson, Jason Roszik, Jibran Ahmed, et al.
Pancreas
|
March 14, 2014
Should combination chemotherapy serve as the backbone in clinical trials of advanced pancreatic cancer? A pooled analysis of phase II trials of gemcitabine-containing doublets plus bevacizumab
Katherine Van Loon, Anne M Espinoza, David R Fogelman, et al.
Journal of Immunotherapy and Precision Oncology
|
January 16, 2025
Safety and Efficacy of Toripalimab in Patients with Cholangiocarcinoma: An Open-Label, Phase 1 Study
Aung Naing, Amit Mahipal, Milind Javle, et al.
Page
of 35